Renin–Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study
Background Angiotensin‐converting enzyme inhibitors (ACE‐Is) and angiotensin receptor blockers (ARBs) may worsen the prognosis of coronavirus disease 2019, but any association could be confounded by the cardiometabolic conditions indicating ACE‐I/ARB use. We therefore examined the impact of ACE‐Is/A...
Main Authors: | Christian Fynbo Christiansen, Uffe Heide‐Jørgensen, Thomas Bøjer Rasmussen, Jacob Bodilsen, Ole Schmeltz Søgaard, Michael Maeng, Simon Tilma Vistisen, Morten Schmidt, Anton Pottegård, Lars Christian Lund, Mette Reilev, Jesper Hallas, Nanna Borup Johansen, Nikolai Constantin Brun, Henrik Toft Sørensen, Reimar Wernich Thomsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.017297 |
Similar Items
-
Medicinal chemistry of the renin-angiotensin system /
by: Timmermans, P. B. M. W. M., et al.
Published: (1994) -
RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01) -
Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
by: Bilgehan Karadağ
Published: (2020-07-01) -
Classical and Alternative Pathways of the Renin–Angiotensin–Aldosterone System in Regulating Blood Pressure in Hypertension and Obese Adolescents
by: Adrian Martyniak, et al.
Published: (2024-03-01) -
Renin-Angiotensin System: A Review of Historical Perspectives
by: Olga Kovalyova, et al.
Published: (2023-05-01)